Skip To Main Content
Bara Badwan on Muck Rack

Bara Badwan

As seen in: Nature, Medical Xpress, BioRxiv, Cell Press, BioSpace, BiopharmaTrend
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bara

Contact Bara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

|
By Dimitrios Skaltsas, Bara Badwan, Panos Karelis
| BioSpace Verified
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often going public before generating revenue, valuations hinge on the potential for FDA approval of their assets.
Open in Who Shared Issue with article?

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

|
By Dimitrios Skaltsas, Bara Badwan, Panos Karelis
| BiopharmaTrend Verified
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often going public before generating revenue, valuations hinge on the potential for FDA approval of their assets.
Open in Who Shared Issue with article?
|
By Ryosuke Tanaka, Baohua Zhou, Margarida Agrochao, Bara Badwan, Braedyn Au, Damon Clark, Natalia C.B. Matos
| Cell Press Verified
Open in Who Shared Issue with article?
See all 22 articles